Trial Profile
Efficacy of Dimethyl Fumarate versus Interferon-beta-1a in patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 May 2017
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary) ; Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 04 May 2017 New trial record
- 28 Apr 2017 Results presented at the 69th Annual Meeting of the American Academy of Neurology